2023 American Academy of Neurology Abstract Website

Adam Quick¹, Alexandra Miller², James Siegler³, Robert Rook⁴, Michaela Morris⁴, Zach Cramer⁴, Xiaoyu Sun⁴, Calli Cook⁵, Behnam Sabayan⁶, Jeff Kraakevik⁷, Jeremy Moeller⁸, Richard Isaacson⁹, Zachary London¹⁰, Roy Strowd¹¹
¹The Ohio State University, ²Neurology, Memorial Sloan Kettering Cancer Center, ³Cooper University Health Care, ⁴American Academy of Neurology, ⁵Emory Healthcare, ⁶HealthPartners Institute, ⁷Oregon Health & Science University, ⁸Yale University, ⁹Florida Atlantic University, ¹⁰University of Michigan, ¹¹Wake Forest University

Objective:

Determine the impact of the AAN NeuroBytes eLearning program on learning and neurological practice.

Background:

NeuroBytes are brief multimedia videos that provide focused, clinically relevant topic updates in neurology. Neurobytes were launched in January 2019 to deliver microlearning in neurology. We assessed the impact of Neurobytes on satisfaction, learning, and practice.

Design/Methods:

We conducted a programmatic review to evaluate all NeuroBytes from January 2019 (launch) to date of analysis (October 2022). Each NeuroByte course included the video and a survey. Assessment data included: course enrollments, completion rate, satisfaction, and influence on practice. Course enrollment was defined as opening for viewing; course completion required completing the post-course survey which assessed user satisfaction and influence on practice. Data were stratified by user type. To assess the program’s impact, four primary outcomes were defined: (1) course enrollments, (2) course completion rate, (3) satisfaction rate, and (4) percent reporting a change in practice. Descriptive statistics were performed.

Results:

From Jan 2019 – Sept 2022 104 NeuroBytes were released. Total enrollments were 65,089; mean enrollments of 598+377 per course. Mean course completion was 39% (range 7% to 92%). On post-course survey, 87% were satisfied/extremely satisfied. Courses covered 20 subspecialties and COVID-19. The most frequent topics were neuromuscular (n=10) and vascular (n=9). The most popular NeuroByte courses were ‘Dual antiplatelet therapy in ischemic stroke’ (n=1,851 enrollments) and ‘The neurologic exam via telemedicine’ (n=1,848). Member neurologists accounted for 55% of course enrollments, followed by juniors (18%), non-AAN members (13%), APP (6%), or student (3%).

Conclusions:

NeuroBytes are a successful microlearning tool for delivering continuing professional development. The primary strengths of the program are accessibility, high-yield learning, breadth of topics, and appeal to a range of learners. Not all content is conducive to micro-delivery. Ongoing efforts will define how this program influences daily practice and lifelong learning.